Literature DB >> 16039090

[Prevention of venous thromboembolism in surgery and obstetrics].

C-M Samama1, P Albaladejo, S Laversin, E Marret.   

Abstract

The French Society of anaesthesiology and intensive care has chosen a high level methodology to issue professional Recommendations on perioperative and obstetrical venous thromboembolism prophylaxis. In addition with a short review on mechanical and pharmacological prophylaxis, all surgical and obstetrical settings have been studied. The initiation and duration of prophylaxis have been particularly debated in close relation with the level of surgical risk. A large group of experts has been involved in this process. More than 150 other experts have participated in the reading process. Didactic tables have been added to help the prescription.

Entities:  

Mesh:

Year:  2005        PMID: 16039090     DOI: 10.1016/j.annfar.2005.06.011

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  3 in total

1.  Risk of Pulmonary Embolism More Than 6 Weeks After Surgery Among Cancer-Free Middle-aged Patients.

Authors:  Alexandre Caron; Nicolas Depas; Emmanuel Chazard; Cécile Yelnik; Emmanuelle Jeanpierre; Camille Paris; Jean-Baptiste Beuscart; Grégoire Ficheur
Journal:  JAMA Surg       Date:  2019-12-01       Impact factor: 14.766

2.  [Practice of prophylaxis for venous thromboembolic disease: survey of health professionals in Ouagadougou].

Authors:  Dangwe Temoua Naibe; André Samadoulougou; Hervé Kabore; Relwendé Aristide Yameogo; Georges Millogo; Nobila Valentin Yameogo; Jonas Koudougou Kologo; Boubacar Jean Yves Toguyeni; Patrice Zabsonre
Journal:  Pan Afr Med J       Date:  2014-12-19

3.  IT-CARES: an interactive tool for case-crossover analyses of electronic medical records for patient safety.

Authors:  Alexandre Caron; Emmanuel Chazard; Joris Muller; Renaud Perichon; Laurie Ferret; Vassilis Koutkias; Régis Beuscart; Jean-Baptiste Beuscart; Grégoire Ficheur
Journal:  J Am Med Inform Assoc       Date:  2017-03-01       Impact factor: 4.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.